The American Cancer Society (ACS) has released a new study predicting a significant increase in the prevalence of cancer among men globally over the coming decades. According to the study, the number of cancer cases among men is expected to rise by approximately 84%, from 10.3 million in 2022 to 19 million by 2050. Furthermore, male cancer deaths are projected to increase by 93%, reaching 10.5 million by 2050.

The study, conducted by Australian researchers, analyzed mortality rates tied to 30 different types of cancer among adult men in 2022, utilizing data from the International Agency for Research on Cancer across 185 countries and territories. The findings revealed that cases are expected to more than double among men aged 65 and older, as well as for those residing in areas with a low or medium Human Development Index (HDI).

The researchers highlighted that poorer survival rates are anticipated for rare cancers such as pancreatic cancer. The study also emphasized the concerning statistics that show men are currently 43% more likely to die from cancer than women and have a higher diagnosis rate of 19%. This disparity is attributed to men's greater engagement in modifiable risk factors like smoking and alcohol consumption, as well as their lower likelihood of undergoing regular screenings for male-specific cancers.

The study identified the 10 cancers with the highest age-standardized mortality rates among men: lung cancer, liver cancer, colorectal cancer, stomach cancer, prostate cancer, esophageal cancer, pancreatic cancer, leukemia, bladder cancer, and cancers of the brain and central nervous system. To address the anticipated surge in cancer cases, the researchers emphasized the importance of reducing modifiable risk factors and increasing accessibility to male-specific screenings.

The study authors emphasized the need for strengthening health infrastructure, enhancing workforce quality and access, fostering national and international collaborations, and promoting universal health coverage to reduce cancer disparities and ensure cancer equity among men globally. They acknowledged some limitations of the study, including the quality of data provided by certain countries and territories, which could impact the accuracy of estimates in low-HDI and medium-HDI countries due to their less developed cancer registries and civil and vital statistics registration systems. Additionally, the study noted that certain measures of cancer burden, such as years of life lost or years lived with disability, were not available in the original data and could not be included in the analysis.

Fox News Digital reached out to the ACS and physicians for comment on the study's findings. To stay informed about the latest health and wellness news, subscribe to Fox News' weekly recap. By subscribing, you agree to receive content and promotional communications from Fox News while retaining the ability to opt-out at any time.